Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Nutrients ; 15(11)2023 May 25.
Artigo em Inglês | MEDLINE | ID: mdl-37299434

RESUMO

Tooth loss and decreased masticatory function reportedly affect cognitive function; tooth loss allegedly induces astrogliosis and aging of astrocytes in the hippocampus and hypothalamus, which is a response specific to the central nervous system owing to homeostasis in different brain regions. Capsaicin, a component of red peppers, has positive effects on brain disorders in mice. Decreased expression of transient receptor potential vanilloid 1, a receptor of capsaicin, is associated with the development of dementia. In this study, we investigated the effect of capsaicin administration in aged mice (C57BL/6N mice) with reduced masticatory function owing to the extraction of maxillary molars to investigate preventive/therapeutic methods for cognitive decline attributed to age-related masticatory function loss. The results demonstrated that mice with impaired masticatory function showed decreased motor and cognitive function at the behavioral level. At the genetic level, neuroinflammation, microglial activity, and astrogliosis, such as increased glial fibrillary acidic protein levels, were observed in the mouse brain. The mice with extracted molars fed on a diet containing capsaicin for 3 months demonstrated improved behavioral levels and astrogliosis, which suggest that capsaicin is useful in maintaining brain function in cases of poor oral function and prosthetic difficulties.


Assuntos
Capsaicina , Perda de Dente , Camundongos , Animais , Capsaicina/farmacologia , Gliose/tratamento farmacológico , Perda de Dente/tratamento farmacológico , Camundongos Endogâmicos C57BL , Encéfalo/metabolismo , Canais de Cátion TRPV/metabolismo
2.
Molecules ; 28(2)2023 Jan 14.
Artigo em Inglês | MEDLINE | ID: mdl-36677905

RESUMO

Periodontitis is caused by pathogens in the oral cavity. It is a chronic infectious disease that causes symptoms including gingival bleeding and tooth loss resulting from the destruction of periodontal tissues coupled with inflammation. Dendropanax morbiferus H.Lév (DM) is a natural product that exhibits various biological activities with few side effects. In this study, the potential of DM leaf hot-water extracts (DMWE) as a treatment for periodontitis was determined and its anti-oxidant and anti-inflammatory effects were evaluated. Compounds in DMWE were identified by high-performance liquid chromatography (HPLC) and nitric oxide (NO) and prostaglandin E2 (PGE2) production was measured in RAW 264.7 cells. We measured the gingival index and gingival sulcus depth, and micro-CT was performed in vivo using a ligature-induced periodontitis rat model, which is similar to human periodontitis. The DMWE-treated group exhibited a decrease in cytokine concentration and relieved the gingival index and gingival sulcus depth compared with the periodontitis-induced control group. In addition, micro-CT and histological analysis revealed that DMWE exhibited anti-inflammatory effects and improved alveolar bone loss in periodontitis-induced rats. These findings suggest that DMWE has excellent anti-oxidant and anti-inflammatory effects that protect and prevent periodontal tissue damage and tooth loss caused by the inflammatory response.


Assuntos
Perda do Osso Alveolar , Periodontite , Perda de Dente , Ratos , Humanos , Animais , Antioxidantes/farmacologia , Antioxidantes/uso terapêutico , Perda de Dente/complicações , Perda de Dente/tratamento farmacológico , Modelos Animais de Doenças , Periodontite/patologia , Perda do Osso Alveolar/tratamento farmacológico , Perda do Osso Alveolar/etiologia , Perda do Osso Alveolar/patologia , Anti-Inflamatórios/farmacologia , Anti-Inflamatórios/uso terapêutico , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico
3.
Epidemiol Psychiatr Sci ; 30: e38, 2021 May 25.
Artigo em Inglês | MEDLINE | ID: mdl-34030762

RESUMO

AIMS: Depression severely affects people's health and well-being. Oral diseases have been suggested to be associated with depression, but so far, there is no causal evidence. This study aimed to identify the causal effect of tooth loss on depression among US adults in a natural experiment study. METHODS: Instrumental variable analysis was conducted using data from 169 061 respondents born in 1940-1978 who participated in the 2006, 2008 or 2010 waves of the Behavioral Risk Factor Surveillance System (BRFSS). Random variation in tooth loss due to differential childhood exposure to drinking water fluoride was exploited as an instrument. RESULTS: US adults who were exposed to drinking water fluoride in childhood had more remaining teeth, therefore providing a robust instrument (F = 73.4). For each additional tooth loss, depressive symptoms according to the eight-item Patient Health Questionnaire depression (PHQ-8) score increased by 0.146 (95% CI 0.008-0.284), and the probability of having clinical depression (PHQ ⩾10) increased by 0.81 percentage points (95% CI -0.12 to 1.73). CONCLUSIONS: Tooth loss causally increased depression among US adults. Losing ten or more teeth had an impact comparable to adults with major depressive disorder not receiving antidepressant drugs.


Assuntos
Transtorno Depressivo Maior , Perda de Dente , Adulto , Idoso de 80 Anos ou mais , Antidepressivos/uso terapêutico , Sistema de Vigilância de Fator de Risco Comportamental , Depressão/epidemiologia , Transtorno Depressivo Maior/tratamento farmacológico , Humanos , Perda de Dente/tratamento farmacológico , Perda de Dente/epidemiologia , Estados Unidos/epidemiologia
4.
Stem Cell Rev Rep ; 16(1): 41-55, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31834583

RESUMO

Tooth defect and tooth loss are common clinical diseases in stomatology. Compared with the traditional oral restoration treatment, tooth regeneration has unique advantages and is currently the focus of oral biomedical research. It is known that dozens of cytokines/growth factors and other bioactive factors are expressed in a spatial-temporal pattern during tooth development. On the other hand, the technology for spatial-temporal control of drug release has been intensively studied and well developed recently, making control release of these bioactive factors mimicking spatial-temporal pattern more feasible than ever for the purpose of tooth regeneration. This article reviews the research progress on the tooth development and discusses the future of tooth regeneration in the context of spatial-temporal release of developmental factors.


Assuntos
Regeneração/efeitos dos fármacos , Engenharia Tecidual , Perda de Dente/tratamento farmacológico , Dente/crescimento & desenvolvimento , Plásticos Biodegradáveis/uso terapêutico , Citocinas/genética , Liberação Controlada de Fármacos/fisiologia , Humanos , Dente/efeitos dos fármacos , Perda de Dente/genética , Perda de Dente/patologia
5.
Eksp Klin Farmakol ; 77(9): 23-7, 2014.
Artigo em Russo | MEDLINE | ID: mdl-25365866

RESUMO

The aim of the work was to study the experience of using complex pharmacotherapy in the treatment of mandibular fractures in elderly patients with incomplete secondary periodontitis, which were divided into two groups. In the first group, patients (n = 46; average age 69.0 ± 3.6) were treated using the authors' original device combined with application of antimicrobial MetrogilDenta gel onto gums two times a day during ten days. Patients in the second group (n = 52; average age 61.0 ± 3.1) were treated with the same device combined with (i) application of MetrogilDenta antimicrobial gel onto gums two times a day during ten days, (ii) application of 1.5 ml of Cycloferon 5% liniment by cotton pellet for 20 min during the same 10 days (30 minutes after the antimicrobial gel), and (iii) intramuscular injections of 6 mg of synthetic immunomodulator Polyoxidonium once a day for 3 days, then once every two days (for a total of 17 days). It is established that the use of the combination of interferon inducers of immunomodulator group--Cycloferon in the form of liniment and synthetic immunomodulator Polyoksidonium together with MetrogilDenta antimicrobial gel--led to the most pronounced regression of inflammatory and destructive processes in periodontal tissues (in 7.1%, d = 0.05), optimized the state of local immunity of the oral cavity, and normalized microflora in periodontal pockets in elderly patients with incomplete secondary adentia.


Assuntos
Acridinas/uso terapêutico , Fatores Imunológicos/uso terapêutico , Indutores de Interferon/uso terapêutico , Fraturas Mandibulares/tratamento farmacológico , Periodontite/tratamento farmacológico , Piperazinas/uso terapêutico , Polímeros/uso terapêutico , Perda de Dente/tratamento farmacológico , Administração Tópica , Idoso , Esquema de Medicação , Feminino , Géis , Humanos , Injeções Intramusculares , Masculino , Fraturas Mandibulares/complicações , Fraturas Mandibulares/imunologia , Fraturas Mandibulares/patologia , Pessoa de Meia-Idade , Periodontite/complicações , Periodontite/imunologia , Periodontite/patologia , Perda de Dente/complicações , Perda de Dente/imunologia , Perda de Dente/patologia , Resultado do Tratamento
6.
Oral Dis ; 12(5): 500-5, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16910922

RESUMO

BACKGROUND: Herpes zoster (HZ) infection of the trigeminal nerve is associated with complications such as postherpetic neuralgia, facial scarring, loss of hearing ability and conjunctivitis. Until 2005, postherpetic alveolar necrosis and spontaneous tooth exfoliation have been described in 20 cases unrelated to HIV infection. OBJECTIVE: The aim of this study was to describe HIV infection in patients (two women, two men, average age 30 years) who suffered from HZ attacks to their trigeminal nerves. MAIN OUTCOME MEASURES: None of the patients had received antiherpetic medications or antiretroviral therapy. HIV infection was only diagnosed after the development of HZ. Facial scarring with depigmentation and hyperesthesia (postherpetic neuralgia) was diagnosed in all four patients. Oral findings consisted of spontaneous loss of both maxillary or mandibular teeth. Osteonecrosis of varying extent was also found. Treatment consisted of extractions of teeth and administration of antibiotics and analgesics. Healing of alveolar wounds was unremarkable. CONCLUSION: Complications affecting the alveolar bone and teeth seem to be rare in HIV-infected patients.


Assuntos
Infecções por HIV/complicações , Herpes Zoster/complicações , Perda de Dente/virologia , Doenças do Nervo Trigêmeo/virologia , Adulto , Cicatriz/etiologia , Cicatriz/virologia , Dermatoses Faciais/patologia , Dermatoses Faciais/virologia , Neuralgia Facial/virologia , Fácies , Feminino , Herpes Zoster/tratamento farmacológico , Humanos , Masculino , Dermatopatias Virais/patologia , Dermatopatias Virais/virologia , Perda de Dente/tratamento farmacológico , Mobilidade Dentária/tratamento farmacológico , Mobilidade Dentária/virologia , Doenças do Nervo Trigêmeo/complicações
7.
J Periodontol ; 77(6): 1061-6, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16734582

RESUMO

BACKGROUND: Statins have anti-inflammatory and bone stimulating properties that may positively affect chronic periodontitis. Our objective in this study was to evaluate whether statin use by chronic periodontitis patients had a beneficial impact on tooth loss. METHODS: In a retrospective cohort study (N patients = 1,021; mean follow-up = 7.1 years), dental records were merged with pharmacy data. Any statin use during 3 years, statin use during each of 3 consecutive years (regular use), and any statin use during the first 3 years after the initial periodontal exam were evaluated as predictors of tooth loss using negative binomial regression models with adjustment for potential confounding factors. RESULTS: Any statin use during 3 years was not associated with tooth loss rate in the year subsequent to the 3-year period (rate ratio [RR] = 1.00; 95% confidence interval [CI] = 0.56 to 1.81). Regular statin use during 3 years was associated with a non-significant 37% reduced tooth loss rate in the year subsequent to the 3-year period (RR = 0.63; 95% CI = 0.32 to 1.25). Any statin use during the first 3 years after the initial periodontal exam was associated with a 48% decreased tooth loss rate in year 4 and subsequent years (RR = 0.52; 95% CI = 0.29 to 0.95). CONCLUSIONS: Our findings were mixed for an association of statin use with reduced tooth loss in chronic periodontitis patients. Lack of control for some potential confounders, particularly smoking, and evaluation of different patterns of statin usage hamper the interpretation of the results. Exploration of these findings in additional epidemiological studies may be worthwhile.


Assuntos
Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico , Periodontite/tratamento farmacológico , Perda de Dente/tratamento farmacológico , Adulto , Fatores Etários , Doença Crônica , Métodos Epidemiológicos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores Sexuais , Fatores de Tempo , Perda de Dente/prevenção & controle
9.
Ned Tijdschr Geneeskd ; 149(32): 1769-72, 2005 Aug 06.
Artigo em Holandês | MEDLINE | ID: mdl-16121659

RESUMO

A 53-year-old woman was referred because of progressive haematomas of the lower extremities and fatigue. Her medical history included hyperplastic gums and tooth loss. Scurvy was diagnosed; this was the result of an insufficient diet due to a paranoid psychosis. There was a dramatic improvement within a few days after addition of vitamin C and starting highly nutritious food. Scurvy is easily treated, but is not a disease of the past.


Assuntos
Deficiência de Ácido Ascórbico/diagnóstico , Deficiência de Ácido Ascórbico/tratamento farmacológico , Ácido Ascórbico/uso terapêutico , Esquizofrenia/complicações , Ácido Ascórbico/administração & dosagem , Deficiência de Ácido Ascórbico/patologia , Contusões/tratamento farmacológico , Contusões/etiologia , Dieta , Fadiga/tratamento farmacológico , Fadiga/etiologia , Feminino , Humanos , Pessoa de Meia-Idade , Psicologia do Esquizofrênico , Perda de Dente/tratamento farmacológico , Perda de Dente/etiologia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA